The evolution of antiandrogens: MDV3100 comes of age

Expert Rev Anticancer Ther. 2012 Feb;12(2):131-3. doi: 10.1586/era.11.210.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Androgen Antagonists / pharmacology
  • Androgen Antagonists / therapeutic use*
  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Humans
  • Male
  • Nitriles
  • Phenylthiohydantoin / analogs & derivatives*
  • Phenylthiohydantoin / pharmacology
  • Phenylthiohydantoin / therapeutic use
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / drug therapy*
  • Randomized Controlled Trials as Topic / trends*
  • Testosterone / blood

Substances

  • Androgen Antagonists
  • Antineoplastic Agents
  • Benzamides
  • Nitriles
  • Phenylthiohydantoin
  • Testosterone
  • enzalutamide